Total Holdings
61
Portfolio diversification across 61 positions
PTH
(NASDAQ)Invesco Dorsey Wright Healthcare Momentum ETF
$49.07-- (--)
Loading... - Market loading
PTH ETF Holdings: Invesco Dorsey Wright Healthcare Momentum ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$123.91M
Total fund assets
Expense Ratio
0.60%
Annual management fee
Fund Issuer
Invesco
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Cidara Therapeutics Inc | Stock | 6.34% |
| 2 |  | Praxis Precision Medicines, Inc. | Stock | 5.11% |
| 3 |  | Insmed Incorporated | Stock | 5.09% |
| 4 |  | Medpace Holdings, Inc | Stock | 4.76% |
| 5 |  | Guardant Health, Inc | Stock | 4.55% |
| 6 |  | Terns Pharmaceuticals, Inc. | Stock | 4.36% |
| 7 |  | Roivant Sciences Ltd. | Stock | 4.24% |
| 8 |  | Arrowhead Pharmaceuticals, Inc. | Stock | 4.10% |
| 9 |  | Natera, Inc | Stock | 3.77% |
| 10 |  | Celcuity LLC | Stock | 3.54% |
| 11 |  | Nektar Therapeutics | Stock | 3.48% |
| 12 |  | Tenet Healthcare Corporation | Stock | 3.46% |
| 13 |  | Revolution Medicines, Inc. | Stock | 3.29% |
| 14 |  | Boston Scientific Corporation | Stock | 3.20% |
| 15 |  | Madrigal Pharmaceuticals, Inc | Stock | 2.96% |
| 16 |  | Axsome Therapeutics, Inc. | Stock | 2.91% |
| 17 |  | HCA Healthcare, Inc. | Stock | 2.87% |
| 18 |  | United Therapeutics Corporation | Stock | 2.62% |
| 19 |  | Travere Therapeutics Inc | Stock | 2.50% |
| 20 |  | Hims & Hers Health, Inc | Stock | 2.46% |
| 21 |  | BridgeBio Pharma, Inc. | Stock | 2.44% |
| 22 |  | Cogent Biosciences, Inc. | Stock | 2.33% |
| 23 |  | Ionis Pharmaceuticals, Inc | Stock | 2.30% |
| 24 |  | Alnylam Pharmaceuticals, Inc | Stock | 2.26% |
| 25 |  | Protagonist Therapeutics Inc | Stock | 2.19% |
| 26 |  | Mineralys Therapeutics Inc. Common Stock | Stock | 1.99% |
| 27 |  | Stoke Therapeutics, Inc. | Stock | 1.94% |
| 28 |  | Alphatec Holdings Inc | Stock | 1.93% |
| 29 |  | The Ensign Group, Inc. | Stock | 1.90% |
| 30 |  | Harrow, Inc. | Stock | 1.90% |
| 31 |  | RadNet Inc | Stock | 1.85% |
| 32 |  | BrightSpring Health Services Inc. Common Stock | Stock | 1.81% |
| 33 |  | Arcutis Biotherapeutics, Inc | Stock | 1.79% |
| 34 |  | PACS Group, Inc. | Stock | 1.70% |
| 35 |  | Alignment Healthcare, Inc. | Stock | 1.67% |
| 36 |  | Doximity, Inc. | Stock | 1.67% |
| 37 |  | PTC Therapeutics, Inc | Stock | 1.64% |
| 38 |  | Immunome, Inc. | Stock | 1.64% |
| 39 |  | Ligand Pharmaceuticals Incorporated | Stock | 1.44% |
| 40 |  | iRhythm Technologies, Inc | Stock | 1.43% |
| 41 |  | ResMed Inc | Stock | 1.38% |
| 42 |  | Kymera Therapeutics, Inc | Stock | 1.24% |
| 43 |  | Mirum Pharmaceuticals Inc | Stock | 1.23% |
| 44 |  | Rhythm Pharmaceuticals, Inc | Stock | 1.23% |
| 45 |  | GeneDx Holdings Corp. | Stock | 1.19% |
| 46 |  | Liquidia Corporation | Stock | 1.17% |
| 47 | M MRUS | Merus BV | Stock | 1.16% |
| 48 |  | Trevi Therapeutics Inc | Stock | 1.04% |
| 49 |  | AxoGen, Inc | Stock | 1.02% |
| 50 |  | Encompass Health Corporation | Stock | 0.99% |